$2.47T
Total marketcap
$83.37B
Total volume
BTC 51.99%     ETH 14.25%
Dominance

ResMed Inc. RMD.AX Stock

33.1 AUD {{ price }} 1.223235% {{change_pct}}%
COUNTRY
Australia
Exchange
ASX
Market Cap
48.93B AUD
LOW - HIGH [24H]
32.9 - 33.26 AUD
VOLUME [24H]
1.52M AUD
{{ volume }}
P/E Ratio
33.77
Earnings per share
0.98 AUD

ResMed Inc. Price Chart

ResMed Inc. RMD.AX Financial and Trading Overview

ResMed Inc. stock price 33.1 AUD
Previous Close 31.81 AUD
Open 31.79 AUD
Bid 31.7 AUD x 0
Ask 31.79 AUD x 0
Day's Range 31.7 - 31.95 AUD
52 Week Range 27.83 - 36.37 AUD
Volume 1.38M AUD
Avg. Volume 1.05M AUD
Market Cap 46.86B AUD
Beta (5Y Monthly) 0.480633
PE Ratio (TTM) 36.860466
EPS (TTM) 0.98 AUD
Forward Dividend & Yield 0.26 (0.82%)
Ex-Dividend Date May 10, 2023
1y Target Est 36.37 AUD

RMD.AX Valuation Measures

Enterprise Value 20.18B AUD
Trailing P/E 36.860466
Forward P/E 29.08257
PEG Ratio (5 yr expected) 1.26
Price/Sales (ttm) 11.670513
Price/Book (mrq) 4.7373533
Enterprise Value/Revenue 5.025
Enterprise Value/EBITDA 16.097

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.480633
52-Week Change 11.34%
S&P500 52-Week Change 20.43%
52 Week High 36.37 AUD
52 Week Low 27.83 AUD
50-Day Moving Average 33.65 AUD
200-Day Moving Average 32.93 AUD

RMD.AX Share Statistics

Avg. Volume (3 month) 1.05M AUD
Avg. Daily Volume (10-Days) 1.29M AUD
Shares Outstanding 1.47B
Float 582.27M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 7.55%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.74
Trailing Annual Dividend Yield 5.46%
5 Year Average Dividend Yield N/A
Payout Ratio 0.2969
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 21.49%
Operating Margin (ttm) 27.92%
Gross Margin 57.00%
EBITDA Margin 31.21%

Management Effectiveness

Return on Assets (ttm) 12.06%
Return on Equity (ttm) 23.93%

Income Statement

Revenue (ttm) 4.02B AUD
Revenue Per Share (ttm) 6.85 AUD
Quarterly Revenue Growth (yoy) 29.19%
Gross Profit (ttm) 2.06B AUD
EBITDA 1.25B AUD
Net Income Avi to Common (ttm) 862.95M AUD
Diluted EPS (ttm) 0.86
Quarterly Earnings Growth (yoy) 29.89%

Balance Sheet

Total Cash (mrq) 240.01M AUD
Total Cash Per Share (mrq) 0.41 AUD
Total Debt (mrq) 1.72B AUD
Total Debt/Equity (mrq) 43.84 AUD
Current Ratio (mrq) 3.069
Book Value Per Share (mrq) 6.6915

Cash Flow Statement

Operating Cash Flow (ttm) 535.35M AUD
Levered Free Cash Flow (ttm) 288.28M AUD

Profile of ResMed Inc.

Country Australia
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858 836 5000
Website https://www.resmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 8160

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current RMD.AX stock price?

ResMed Inc. RMD.AX stock price today per share is 33.1 AUD.

How to purchase ResMed Inc. stock?

You can buy RMD.AX shares on the ASX exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is RMD.AX.

Which industry does the ResMed Inc. company belong to?

The ResMed Inc. industry is Medical Instruments & Supplies.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 1.48B.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 33.77551000 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 0.98 AUD over the trailing 12 months.

Which sector does the ResMed Inc. company belong to?

The ResMed Inc. sector is Healthcare.

ResMed Inc. RMD.AX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
S&P/ASX 300 AXKO 7829.1 AUD 5181.75 USD
+1.63
7703.9 AUD 5098.88 USD 7847.4 AUD 5193.86 USD
S&P/ASX 200 EQUAL WEIGHT AXEW 1909.4 AUD 1263.75 USD
+1.32
1884.6 AUD 1247.34 USD 1914.9 AUD 1267.39 USD
ALL ORDINARIES AORD 8150.1 AUD 5394.2 USD
+1.61
8020.9 AUD 5308.69 USD 8167.3 AUD 5405.59 USD
S&P/ASX 200 Net Total Rtn AXNT 94865 AUD 62787.08 USD
+1.65
93329.2 AUD 61770.6 USD 95092.1 AUD 62937.39 USD
S&P/ASX 200 AXJO 7881.3 AUD 5216.29 USD
+1.65
7753.7 AUD 5131.84 USD 7900.2 AUD 5228.8 USD
S&P/ASX 100 ATOI 6615.9 AUD 4378.78 USD
+1.69
6506 AUD 4306.04 USD 6632 AUD 4389.44 USD
S&P/ASX 50 AFLI 7724.2 AUD 5112.32 USD
+1.72
7593.7 AUD 5025.94 USD 7744.2 AUD 5125.55 USD